Use of mycophenolic acid in superifical bladder cancer

J G Connolly et al. Urology. 1975 Jan.

. 1975 Jan;5(1):131-2.

doi: 10.1016/0090-4295(75)90323-4.

No abstract available

Similar articles

Experimental antitumor activity and preclinical toxicology of mycophenolic acid.
Sweeney MJ, Gerzon K, Harris PN, Holmes RE, Poore GA, Williams RH. Sweeney MJ, et al. Cancer Res. 1972 Sep;32(9):1795-802. Cancer Res. 1972. PMID: 4509039 No abstract available.
[Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
Okajima E, Hiramatsu T, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Tanaka M, Maruyama Y. Okajima E, et al. Gan To Kagaku Ryoho. 1982 Mar;9(3):473-9. Gan To Kagaku Ryoho. 1982. PMID: 6820898 Japanese.
Developmental concepts: effective chemotherapy for bladder carcinoma.
Anderson T. Anderson T. Semin Oncol. 1979 Jun;6(2):240-8. Semin Oncol. 1979. PMID: 482962 No abstract available.
[Chemotherapy of bladder cancer].
Korol'chuk VP, Shipilov VI, Romanov VA, Matveev BP. Korol'chuk VP, et al. Urol Nefrol (Mosk). 1981 May-Jun;(3):68-72. Urol Nefrol (Mosk). 1981. PMID: 6168085 Review. Russian. No abstract available.
VM 26 and VP 16-213: a comparative analysis.
Rozencweig M, Von Hoff DD, Henney JE, Muggia FM. Rozencweig M, et al. Cancer. 1977 Jul;40(1):334-42. doi: 10.1002/1097-0142(197707)40:1<334::aid-cncr2820400147>3.0.co;2-x. Cancer. 1977. PMID: 328129 Review.

Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
Sidi Y, Panet C, Wasserman L, Cyjon A, Novogrodsky A, Nordenberg J. Sidi Y, et al. Br J Cancer. 1988 Jul;58(1):61-3. doi: 10.1038/bjc.1988.162. Br J Cancer. 1988. PMID: 2901850 Free PMC article. No abstract available.